Investigating hypoxic tumor physiology through gene expression patterns

Nicholas C. Denko, Lucrezia A. Fontana, Karen M. Hudson, Patrick D. Sutphin, Soumya Raychaudhuri, Russ Altman, Amato J. Giaccia

Research output: Contribution to journalArticle

242 Citations (Scopus)

Abstract

Clinical evidence shows that tumor hypoxia is an independent prognostic indicator of poor patient outcome. Hypoxic tumors have altered physiologic processes, including increased regions of angiogenesis, increased local invasion, increased distant metastasis and altered apoptotic programs. Since hypoxia is a potent controller of gene expression, identifying hypoxia-regulated genes is a means to investigate the molecular response to hypoxic stress. Traditional experimental approaches have identified physiologic changes in hypoxic cells. Recent studies have identified hypoxia-responsive genes that may define the mechanism(s) underlying these physiologic changes. For example, the regulation of glycolytic genes by hypoxia can explain some characteristics of the Warburg effect. The converse of this logic is also true. By identifying new classes of hypoxia-regulated gene(s), we can infer the physiologic pressures that require the induction of these genes and their protein products. Furthermore, these physiologically driven hypoxic gene expression changes give us insight as to the poor outcome of patients with hypoxic tumors. Approximately 1-1.5% of the genome is transcriptionally responsive to hypoxia. However, there is significant heterogeneity in the transcriptional response to hypoxia between different cell types. Moreover, the coordinated change in the expression of families of genes supports the model of physiologic pressure leading to expression changes. Understanding the evolutionary pressure to develop a 'hypoxic response' provides a framework to investigate the biology of the hypoxic tumor microenvironment.

Original languageEnglish (US)
Pages (from-to)5907-5914
Number of pages8
JournalOncogene
Volume22
Issue number37 REV. ISS. 3
DOIs
StatePublished - Sep 1 2003

Fingerprint

Gene Expression
Neoplasms
Pressure
Genes
Tumor Microenvironment
Hypoxia
Genome
Neoplasm Metastasis
Proteins

Keywords

  • HIF-1
  • Hypoxic gene induction
  • VHL

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Denko, N. C., Fontana, L. A., Hudson, K. M., Sutphin, P. D., Raychaudhuri, S., Altman, R., & Giaccia, A. J. (2003). Investigating hypoxic tumor physiology through gene expression patterns. Oncogene, 22(37 REV. ISS. 3), 5907-5914. https://doi.org/10.1038/sj.onc.1206703

Investigating hypoxic tumor physiology through gene expression patterns. / Denko, Nicholas C.; Fontana, Lucrezia A.; Hudson, Karen M.; Sutphin, Patrick D.; Raychaudhuri, Soumya; Altman, Russ; Giaccia, Amato J.

In: Oncogene, Vol. 22, No. 37 REV. ISS. 3, 01.09.2003, p. 5907-5914.

Research output: Contribution to journalArticle

Denko, NC, Fontana, LA, Hudson, KM, Sutphin, PD, Raychaudhuri, S, Altman, R & Giaccia, AJ 2003, 'Investigating hypoxic tumor physiology through gene expression patterns', Oncogene, vol. 22, no. 37 REV. ISS. 3, pp. 5907-5914. https://doi.org/10.1038/sj.onc.1206703
Denko NC, Fontana LA, Hudson KM, Sutphin PD, Raychaudhuri S, Altman R et al. Investigating hypoxic tumor physiology through gene expression patterns. Oncogene. 2003 Sep 1;22(37 REV. ISS. 3):5907-5914. https://doi.org/10.1038/sj.onc.1206703
Denko, Nicholas C. ; Fontana, Lucrezia A. ; Hudson, Karen M. ; Sutphin, Patrick D. ; Raychaudhuri, Soumya ; Altman, Russ ; Giaccia, Amato J. / Investigating hypoxic tumor physiology through gene expression patterns. In: Oncogene. 2003 ; Vol. 22, No. 37 REV. ISS. 3. pp. 5907-5914.
@article{98125bbb0e4d401b88c6ef916862d1d9,
title = "Investigating hypoxic tumor physiology through gene expression patterns",
abstract = "Clinical evidence shows that tumor hypoxia is an independent prognostic indicator of poor patient outcome. Hypoxic tumors have altered physiologic processes, including increased regions of angiogenesis, increased local invasion, increased distant metastasis and altered apoptotic programs. Since hypoxia is a potent controller of gene expression, identifying hypoxia-regulated genes is a means to investigate the molecular response to hypoxic stress. Traditional experimental approaches have identified physiologic changes in hypoxic cells. Recent studies have identified hypoxia-responsive genes that may define the mechanism(s) underlying these physiologic changes. For example, the regulation of glycolytic genes by hypoxia can explain some characteristics of the Warburg effect. The converse of this logic is also true. By identifying new classes of hypoxia-regulated gene(s), we can infer the physiologic pressures that require the induction of these genes and their protein products. Furthermore, these physiologically driven hypoxic gene expression changes give us insight as to the poor outcome of patients with hypoxic tumors. Approximately 1-1.5{\%} of the genome is transcriptionally responsive to hypoxia. However, there is significant heterogeneity in the transcriptional response to hypoxia between different cell types. Moreover, the coordinated change in the expression of families of genes supports the model of physiologic pressure leading to expression changes. Understanding the evolutionary pressure to develop a 'hypoxic response' provides a framework to investigate the biology of the hypoxic tumor microenvironment.",
keywords = "HIF-1, Hypoxic gene induction, VHL",
author = "Denko, {Nicholas C.} and Fontana, {Lucrezia A.} and Hudson, {Karen M.} and Sutphin, {Patrick D.} and Soumya Raychaudhuri and Russ Altman and Giaccia, {Amato J.}",
year = "2003",
month = "9",
day = "1",
doi = "10.1038/sj.onc.1206703",
language = "English (US)",
volume = "22",
pages = "5907--5914",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "37 REV. ISS. 3",

}

TY - JOUR

T1 - Investigating hypoxic tumor physiology through gene expression patterns

AU - Denko, Nicholas C.

AU - Fontana, Lucrezia A.

AU - Hudson, Karen M.

AU - Sutphin, Patrick D.

AU - Raychaudhuri, Soumya

AU - Altman, Russ

AU - Giaccia, Amato J.

PY - 2003/9/1

Y1 - 2003/9/1

N2 - Clinical evidence shows that tumor hypoxia is an independent prognostic indicator of poor patient outcome. Hypoxic tumors have altered physiologic processes, including increased regions of angiogenesis, increased local invasion, increased distant metastasis and altered apoptotic programs. Since hypoxia is a potent controller of gene expression, identifying hypoxia-regulated genes is a means to investigate the molecular response to hypoxic stress. Traditional experimental approaches have identified physiologic changes in hypoxic cells. Recent studies have identified hypoxia-responsive genes that may define the mechanism(s) underlying these physiologic changes. For example, the regulation of glycolytic genes by hypoxia can explain some characteristics of the Warburg effect. The converse of this logic is also true. By identifying new classes of hypoxia-regulated gene(s), we can infer the physiologic pressures that require the induction of these genes and their protein products. Furthermore, these physiologically driven hypoxic gene expression changes give us insight as to the poor outcome of patients with hypoxic tumors. Approximately 1-1.5% of the genome is transcriptionally responsive to hypoxia. However, there is significant heterogeneity in the transcriptional response to hypoxia between different cell types. Moreover, the coordinated change in the expression of families of genes supports the model of physiologic pressure leading to expression changes. Understanding the evolutionary pressure to develop a 'hypoxic response' provides a framework to investigate the biology of the hypoxic tumor microenvironment.

AB - Clinical evidence shows that tumor hypoxia is an independent prognostic indicator of poor patient outcome. Hypoxic tumors have altered physiologic processes, including increased regions of angiogenesis, increased local invasion, increased distant metastasis and altered apoptotic programs. Since hypoxia is a potent controller of gene expression, identifying hypoxia-regulated genes is a means to investigate the molecular response to hypoxic stress. Traditional experimental approaches have identified physiologic changes in hypoxic cells. Recent studies have identified hypoxia-responsive genes that may define the mechanism(s) underlying these physiologic changes. For example, the regulation of glycolytic genes by hypoxia can explain some characteristics of the Warburg effect. The converse of this logic is also true. By identifying new classes of hypoxia-regulated gene(s), we can infer the physiologic pressures that require the induction of these genes and their protein products. Furthermore, these physiologically driven hypoxic gene expression changes give us insight as to the poor outcome of patients with hypoxic tumors. Approximately 1-1.5% of the genome is transcriptionally responsive to hypoxia. However, there is significant heterogeneity in the transcriptional response to hypoxia between different cell types. Moreover, the coordinated change in the expression of families of genes supports the model of physiologic pressure leading to expression changes. Understanding the evolutionary pressure to develop a 'hypoxic response' provides a framework to investigate the biology of the hypoxic tumor microenvironment.

KW - HIF-1

KW - Hypoxic gene induction

KW - VHL

UR - http://www.scopus.com/inward/record.url?scp=0141869070&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0141869070&partnerID=8YFLogxK

U2 - 10.1038/sj.onc.1206703

DO - 10.1038/sj.onc.1206703

M3 - Article

C2 - 12947397

AN - SCOPUS:0141869070

VL - 22

SP - 5907

EP - 5914

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 37 REV. ISS. 3

ER -